Clearmind Medicine Inc (CMND.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 04-2022 | 01-2022 | 10-2021 | 07-2021 | 04-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 4 | 10 | N/A | N/A | N/A |
| Accounts receivable | -96 | 30 | -74 | 254 | -305 |
| Accounts payable and accrued liabilities | 6 | -159 | 60 | 205 | 2 |
| Other Working Capital | -57 | -51 | -217 | 534 | -300 |
| Other Operating Activity | -1,891 | -1,230 | -1,197 | -1,323 | 146 |
| Operating Cash Flow | $-2,034 | $-1,400 | $-1,428 | $-330 | $-457 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -19 | 0 | N/A |
| Other Investing Activity | 0 | 0 | -176 | 0 | 0 |
| Investing Cash Flow | $N/A | $N/A | $-195 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 338 | 4,490 | N/A |
| Other Financing Activity | 0 | 0 | -298 | 0 | 0 |
| Financing Cash Flow | $N/A | $N/A | $40 | $4,490 | $N/A |
| Exchange Rate Effect | 1 | 0 | N/A | N/A | N/A |
| Beginning Cash Position | 2,204 | 3,604 | 5,292 | 1,136 | 185 |
| End Cash Position | 784 | 2,204 | 3,727 | 5,292 | 1,136 |
| Net Cash Flow | $-1,371 | $-1,400 | $-1,566 | $4,160 | $940 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,034 | -1,400 | -1,428 | -330 | -457 |
| Capital Expenditure | N/A | N/A | -179 | N/A | N/A |
| Free Cash Flow | -2,034 | -1,400 | -1,606 | -330 | -457 |